Latest Breaking News On - வெளிப்படுகிறது தொழில்நுட்பங்கள் இன்க் - Page 1 : comparemela.com

Developing New Diagnostic Strategies to Prevent DSA-mediated Tissue Injury in Solid Organ Transplantation AUSTIN, Texas and CAMBRIDGE, U.K., July 21, 2021 (SEND2PRESS NEWSWIRE) Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with The University of Cambridge Abdominal Transplant Centre at Addenbrooke’s Hospital, to develop new diagnostic strategies for DSA monitoring and characterization in transplantation. The research is being led by Dr. Vasilis Kosmoliaptsis, Honorary Consultant Abdominal Transplant and HPB Surgeon, and Dr. Rico Buchli, Vice President Products and Services and Director of Research at PTS and its parent company, Pure Protein, LLC. The research project aims to investigate the relationship between alloantibody-HLA binding streng

United statesUnited kingdomVasilis kosmoliaptsisEmergent technologies incUniversity of oklahomaPure proteinPure transplant solutionsDeveloping new diagnostic strategiesTissue injurySolid organCambridge abdominal transplant centreHonorary consultant abdominal transplantRico buchliVice president productsTransplant solutionsEmergent technologies